PMDA drug package insert
ビジパーク270注20mL
PMDA Prescription drug · GEヘルスケアファーマ株式会社 · package insert Jun 2, 2025
Key facts
| Brand names | ビジパーク270注20mL, ビジパーク270注50mL, ビジパーク270注100mL, ビジパーク320注50mL, ビジパーク320注100mL |
|---|---|
| Nonproprietary names | イオジキサノール |
| Companies | 製造販売元／GEヘルスケアファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 非イオン性等浸透圧造影剤 |
| Therapeutic category codes | 877219 |
| YJ codes | 7219420A1031, 7219420A2038, 7219420A3034, 7219420A4030, 7219420A5037 |
| Approval numbers | 22000AMX01217, 22000AMX00828, 22000AMX00827, 22000AMX01216, 22000AMX00829 |
| Package insert edition | 第4版 |
| Package insert date | Jun 2, 2025 |
| PMDA document key | 343048_7219420A1031_2 |
| PMDA company code | 343048 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: